International Business News - RPRX http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus of cash to buy pipeline additions. http://www.ibtimes.com/articles/20080820/biotech-buyout-action-likely-to-continue.htm Wed, 20 Aug 2008 11:41:33 EDT Among the earnings stories for Monday, Aug. 11, from AP Financial News: SALT LAKE CITY (AP)--EnergySolutions Inc., which handles nuclear waste, said Monday second-quarter profit more than doubled, helped by higher international revenue. http://www.ibtimes.com/articles/20080811/earnings-roundup-energysolutions-fuel-tech.htm Mon, 11 Aug 2008 10:18:52 EDT Biotechnology company Repros Therapeutics Inc. said Monday its second-quarter loss widened primarily on higher spending for clinical development programs. http://www.ibtimes.com/articles/20080811/repros-therapeutics-2q-loss-widens-on-costs.htm Mon, 11 Aug 2008 06:47:56 EDT Among the earnings stories for Friday, May 9, from AP Financial News: NEW YORK (AP) _ Auto parts maker Delphi Corp. reported Friday that it lost more money in the first quarter than it did a year ago, but that an expanded credit line will still allow it to emerge intact from bankruptcy protection. http://www.ibtimes.com/articles/20080509/earnings-roundup-delphi-iomega.htm Fri, 09 May 2008 18:31:31 EDT Biotechnology company Repros Therapeutics Inc. said Friday its first-quarter loss widened on higher spending for clinical development programs. The company reported a loss of $6.7 million, or 52 cents per share, compared with a loss of $3.7 million, or 31 cents per share, a year ago. Revenue fell to $269,000 from $318,000. http://www.ibtimes.com/articles/20080509/repros-therapeutics-1q-loss-widens-on-higher-costs.htm Fri, 09 May 2008 18:00:57 EDT